These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1511749)

  • 1. Inhibitory effect of human chorionic gonadotropin (hCG) on HIV-1 transmission from lymphocytes to trophoblasts.
    Bourinbaiar AS; Nagorny R
    FEBS Lett; 1992 Aug; 309(1):82-4. PubMed ID: 1511749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human chorionic gonadotropin (hCG) on reverse transcriptase activity in HIV-1 infected lymphocytes and monocytes.
    Bourinbaiar AS; Nagorny R
    FEMS Microbiol Lett; 1992 Sep; 75(1):27-30. PubMed ID: 1382034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HIV effect of beta subunit of human chorionic gonadotropin (beta hCG) in vitro.
    Bourinbaiar AS; Lee-Huang S
    Immunol Lett; 1995 Jan; 44(1):13-8. PubMed ID: 7536708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of human chorionic gonadotropin (hCG) preparations on HIV infection of human placenta in vitro.
    Polliotti BM; Gnall-Sazenski S; Laughlin TS; Miller RK
    Placenta; 2002 Apr; 23 Suppl A():S102-6. PubMed ID: 11978066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of coumarins on HIV-1 replication and cell-mediated or cell-free viral transmission.
    Bourinbaiar AS; Tan X; Nagorny R
    Acta Virol; 1993 Aug; 37(4):241-50. PubMed ID: 7905238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 infection of choriocarcinoma-derived trophoblasts.
    Bourinbaiar AS; Nagorny R
    Acta Virol; 1993 Feb; 37(1):21-8. PubMed ID: 8105649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 infection of human placenta: potential route for fetal infection.
    Amirhessami-Aghili N; Spector SA
    J Virol; 1991 May; 65(5):2231-6. PubMed ID: 2016757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease.
    Lunardi-Iskandar Y; Bryant JL; Blattner WA; Hung CL; Flamand L; Gill P; Hermans P; Birken S; Gallo RC
    Nat Med; 1998 Apr; 4(4):428-34. PubMed ID: 9546788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 replication by daunorubicin.
    Filion LG; Logan D; Gaudreault R; Izaguirre CA
    Clin Invest Med; 1993 Oct; 16(5):339-47. PubMed ID: 8261687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
    Dubrovsky L; Ulrich P; Nuovo GJ; Manogue KR; Cerami A; Bukrinsky M
    Mol Med; 1995 Jan; 1(2):217-30. PubMed ID: 8529100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assessment of compounds for anti-HIV activity.
    Patience C; Moore J; Boyd M
    Mol Biotechnol; 1994 Feb; 1(1):49-58. PubMed ID: 7532100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 infection of the trophoblast cell line BeWo: a study of virus uptake.
    Phillips DM; Tan X
    AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1683-91. PubMed ID: 1457213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tubeimoside-1 on HIV core protein p24 and cytopathogenesis in vitro.
    Yu LJ; Ma RD; Jiang SB
    Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):103-6. PubMed ID: 8010099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of constant infusion of A-77003, an inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease, in limiting acute HIV-1 infection in vitro.
    Bilello JA; Bilello PA; Kort JJ; Dudley MN; Leonard J; Drusano GL
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2523-7. PubMed ID: 8585738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of HIV-1 replication by propolis and its immunoregulatory effect.
    Harish Z; Rubinstein A; Golodner M; Elmaliah M; Mizrachi Y
    Drugs Exp Clin Res; 1997; 23(2):89-96. PubMed ID: 9309384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curdlan sulfate and HIV-1. I. In vitro inhibitory effects of curdlan sulfate on HIV-1 infection.
    Aoki T; Kaneko Y; Stefanski MS; Nguyen T; Ting RC
    AIDS Res Hum Retroviruses; 1991 Apr; 7(4):409-15. PubMed ID: 1676899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral action of oligodeoxyguanylic acids against human immunodeficiency virus type 1.
    Fujihashi T; Sakata T; Kaji A; Kaji H
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):461-71. PubMed ID: 7543270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The non-steroidal anti-inflammatory drug, indomethacin, as an inhibitor of HIV replication.
    Bourinbaiar AS; Lee-Huang S
    FEBS Lett; 1995 Feb; 360(1):85-8. PubMed ID: 7875307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    Dis Markers; 1990; 8(3):162-3. PubMed ID: 2125537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.